Gorman M (1984) Sir William Brooke O’Shaughnessy, F.R.S. (1809–1889), Anglo-Indian
forensic chemist. Notes and Records of the Roayl Society of London 39 (1):51-64
Gottschling S (2011) Cannbinoide bei Kindern. Gute Erfahrungen bei Schmerzen, Spastik und in
der Onkologie. Angew Schmerztherapie und Palliativmedizin 1:55– 57
Grattan JHG, Singer CJ (1952) Anglo-Saxon magic and medicine. Illustrated specially from the
semi-pagan text“Lacnunga,”. Publications of the Wellcome Historical Medical Museum. New
ser., no. 3. Oxford University Press, London, New York
Greene JJ (1899) Celtic royal genealogy.http://wc.rootsweb.ancestry.com/cgi-bin/igm.cgi?op=
GET&db=aet-t&id=I61019#s1
Greene R (1872)Cannabis indicain the treatment of migraine. Practitioner 41:267– 270
Greene R (1874) Epilepsy and migraine: a clinical note. J Ment Sci 20:96– 97
Greene R (1888) The treatment of migraine with Indian hemp. Practitioner 41:35– 38
Izzo AA, Capasso F, Costagliola A, Bisogno T, Marsicano G, Ligresti A, Matias I, Capasso R,
Pinto L, Borrelli F, Cecio A, Lutz B, Mascolo N, Di Marzo V (2003) An endogenous
cannabinoid tone attenuates cholera toxin-induced fluid accumulation in mice.
Gastroenterology 125(3):765– 774
Izzo AA, Sharkey KA (2010) Cannabinoids and the gut: new developments and emerging
concepts. Pharmacol Ther 126(1):21–38. doi:10.1016/j.pharmthera.2009.12.005(S0163-7258
(10)00006-9 [pii])
King A (2015) Medical marvel: the uses of cannabis continue to grow. Irish scientists are
exploring the chemicals found in cannabis to develop drugs to treat pain, anxiety, MS and
Alzheimer’s. Irish Times, Apr 16
Malfait AM, Gallily R, Sumariwalla PF, Malik AS, Andreakos E, Mechoulam R, Feldmann M
(2000) The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic
therapeutic in murine collagen-induced arthritis. Proc Natl Acad Sci U S A 97(17):9561– 9566
Mikuriya TH (1973) Marijuana: Medical papers, 1839–1872. Medi-comp Press, Oakland, CA
Mikuriya TH (2004) Cannabis as a substitute for alcohol: a harm-reduction approach. Journal of
Cannabis Therapeutics 4(1):79– 93
Mills JH (2003) Cannabis Britannica: empire, trade, and prohibition 1800–1928. Oxford
University Press, Oxford
Moloney MF (1919) Irish Ethno-Botany and the evolution of medicine in Ireland. M. H. Gill and
Son, Dublin
Notcutt W, Langford R, Davies P, Ratcliffe S, Potts R (2012) A placebo-controlled, parallel-group,
randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis
who are receiving long-term Sativex(R) (nabiximols). Mult Scler 18(2):219–228. doi:10.1177/
1352458511419700
Novotna A, Mares J, Ratcliffe S, Novakova I, Vachova M, Zapletalova O, Gasperini C, Pozzilli C,
Cefaro L, Comi G, Rossi P, Ambler Z, Stelmasiak Z, Erdmann A, Montalban X, Klimek A,
Davies P (2011) A randomized, double-blind, placebo-controlled, parallel-group,
enriched-design study of nabiximols* (Sativex((R))), as add-on therapy, in subjects with
refractory spasticity caused by multiple sclerosis. Eur J Neurol 18(9):1122–1131. doi:10.1111/
j.1468-1331.2010.03328.x
Nurmikko TJ, Serpell MG, Hoggart B, Toomey PJ, Morlion BJ, Haines D (2007) Sativex
successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind,
placebo-controlled clinical trial. Pain 133(1–3):210– 220
O’Shaughnessy WB (1838–1840) On the preparations of the Indian hemp, or gunjah(Cannabis
indica); their effects on the animal system in health, and their utility in the treatment of tetanus
and other convulsive diseases. Transactions of the medical and physical society of Bengal:71–
102, 421– 461
O’Shaughnessy WB (1839) On the preparation of the Indian hemp, or Gunjah. J Asiatic Soc
Bengal 8
O’Shaughnessy WB (1842) Bengal dispensatory and companion to the phamacopoeia. Allen,
London
O’Shaughnessy WB (1843a) Indian hemp. Provincial Med J Retrospect Med Sci 5:397– 398
2 History of Cannabis as Medicine: Nineteenth... 77